News

We are happy to announce that MedVasc anesthesia catheter SolutioTM has gained attention from important international newspapers within the industry. Please read and watch a short video of Founder Dr. Michael Åkesson in Venous News talking about the results from our first-in-man study: Vascular Specialist also wrote about the results from our…

MedVasc has closed an investment round of 5 M SEK from existing investors.  The raised capital will be used to initiate manufacturing and final validation of FDA 510k pathway for the company’s anesthesia catheter SolutioTM. SolutioTM improves the golden standard methods for treatment of varicose veins and is expected…

During 2023 MedVasc patent was granted in China, India, Canada, and Brazil. MedVasc’s patent portfolio is strengthened by the progression relating to the company’s medical device, the anesthesia catheter SolutioTM. SolutioTM minimizes the pain when performing the gold standard treatment methods for treating varicose veins and is expected to…

MedVasc anesthesia catheter SolutioTM gained attention during 2023 Veith Symposium in NYC as renowned KOL Dr. Lowell Kabnick gave a talk on center stage about next-generation venous devices. In addition, Dr. Michael Åkesson was also invited to present the results from our first-in-man clinical study….

MedVasc has been selected to join prestigious medtech ac  MedVasc has been selected as 1 of 11 international medtech startups to learn from Medtronic and MedLim partners how to accelerate commercialization.  It all kicked off with a fantastic week in Maastricht followed by digital sessions and 1-1 meetings.  “We feel humble and grateful for the opportunity. It’s been a…